CAROLINE GARMANY: Open Payments
NPI 1548825227 · ROSWELL, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$716 in 11 payments from 10 companies in 2025. Trend: 2023 $427 · 2024 $394 · 2025 $716
Food & beverage: $716
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 1 | $144 |
| Neurocrine BioSciences, Inc. | 1 | $131 |
| Novo Nordisk Inc | 1 | $120 |
| Gilead Sciences, Inc. | 1 | $118 |
| Teleflex LLC | 1 | $87 |
| SANOFI-AVENTIS U.S. LLC | 2 | $47 |
| Amgen Inc. | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Exact Sciences Corporation | 1 | $17 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
Products named: SAPIEN 3 Ultra RESILIA, INGREZZA, Wegovy, Biktarvy, BARRIGEL, TZIELD, REPATHA, AREXVY.
Industry payments across GA — which companies pay providers there.
